114 related articles for article (PubMed ID: 31629859)
1. Axonal regeneration and functional recovery driven by endogenous Nogo receptor antagonist LOTUS in a rat model of unilateral pyramidotomy.
Ueno R; Takase H; Suenaga J; Kishimoto M; Kurihara Y; Takei K; Kawahara N; Yamamoto T
Exp Neurol; 2020 Jan; 323():113068. PubMed ID: 31629859
[TBL] [Abstract][Full Text] [Related]
2. Nogo receptor decoy promotes recovery and corticospinal growth in non-human primate spinal cord injury.
Wang X; Zhou T; Maynard GD; Terse PS; Cafferty WB; Kocsis JD; Strittmatter SM
Brain; 2020 Jun; 143(6):1697-1713. PubMed ID: 32375169
[TBL] [Abstract][Full Text] [Related]
3. Oligodendrocytic but not neuronal Nogo restricts corticospinal axon sprouting after CNS injury.
Meves JM; Geoffroy CG; Kim ND; Kim JJ; Zheng B
Exp Neurol; 2018 Nov; 309():32-43. PubMed ID: 30055160
[TBL] [Abstract][Full Text] [Related]
4. Lateral olfactory tract usher substance (LOTUS), an endogenous Nogo receptor antagonist, ameliorates disease progression in amyotrophic lateral sclerosis model mice.
Ikeda T; Takahashi K; Higashi M; Komiya H; Asano T; Ogasawara A; Kubota S; Hashiguchi S; Kunii M; Tanaka K; Tada M; Doi H; Takeuchi H; Takei K; Tanaka F
Cell Death Discov; 2023 Dec; 9(1):454. PubMed ID: 38097540
[TBL] [Abstract][Full Text] [Related]
5. Restoring Cellular Energetics Promotes Axonal Regeneration and Functional Recovery after Spinal Cord Injury.
Han Q; Xie Y; Ordaz JD; Huh AJ; Huang N; Wu W; Liu N; Chamberlain KA; Sheng ZH; Xu XM
Cell Metab; 2020 Mar; 31(3):623-641.e8. PubMed ID: 32130884
[TBL] [Abstract][Full Text] [Related]
6. Motor recovery and axonal plasticity with short-term amphetamine after stroke.
Papadopoulos CM; Tsai SY; Guillen V; Ortega J; Kartje GL; Wolf WA
Stroke; 2009 Jan; 40(1):294-302. PubMed ID: 19038917
[TBL] [Abstract][Full Text] [Related]
7. Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial.
Howard EM; Strittmatter SM
Curr Opin Neurol; 2023 Dec; 36(6):516-522. PubMed ID: 37865850
[TBL] [Abstract][Full Text] [Related]
8. Delayed anti-nogo-a therapy improves function after chronic stroke in adult rats.
Tsai SY; Papadopoulos CM; Schwab ME; Kartje GL
Stroke; 2011 Jan; 42(1):186-90. PubMed ID: 21088244
[TBL] [Abstract][Full Text] [Related]
9. Eliciting inflammation enables successful rehabilitative training in chronic spinal cord injury.
Torres-Espín A; Forero J; Fenrich KK; Lucas-Osma AM; Krajacic A; Schmidt E; Vavrek R; Raposo P; Bennett DJ; Popovich PG; Fouad K
Brain; 2018 Jul; 141(7):1946-1962. PubMed ID: 29860396
[TBL] [Abstract][Full Text] [Related]
10. Anti-Nogo-A Antibody Therapy Improves Functional Outcome Following Traumatic Brain Injury.
Powers BE; Ton ST; Farrer RG; Chaudhary S; Nockels RP; Kartje GL; Tsai SY
Neurorehabil Neural Repair; 2023 Oct; 37(10):682-693. PubMed ID: 37837331
[TBL] [Abstract][Full Text] [Related]
11. Harnessing cortical plasticity via gabapentinoid administration promotes recovery after stroke.
Tedeschi A; Larson MJE; Zouridakis A; Mo L; Bordbar A; Myers JM; Qin HY; Rodocker HI; Fan F; Lannutti JJ; McElroy CA; Nimjee SM; Peng J; Arnold WD; Moon LDF; Sun W
Brain; 2022 Jul; 145(7):2378-2393. PubMed ID: 35905466
[TBL] [Abstract][Full Text] [Related]
12. A re-assessment of the effects of intracortical delivery of inosine on transmidline growth of corticospinal tract axons after unilateral lesions of the medullary pyramid.
Steward O; Sharp K; Yee KM
Exp Neurol; 2012 Feb; 233(2):662-73. PubMed ID: 21946267
[TBL] [Abstract][Full Text] [Related]
13. Unilateral pyramidotomy of the corticospinal tract in rats for assessment of neuroplasticity-inducing therapies.
Kathe C; Hutson TH; Chen Q; Shine HD; McMahon SB; Moon LD
J Vis Exp; 2014 Dec; (94):. PubMed ID: 25549050
[TBL] [Abstract][Full Text] [Related]
14. Alternative routes for recovery of hand functions after corticospinal tract injury in primates and rodents.
Isa T; Mitsuhashi M; Yamaguchi R
Curr Opin Neurol; 2019 Dec; 32(6):836-843. PubMed ID: 31688166
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome of rat subcortical white matter and spinal cord after spinal injury and cortical stimulation.
Kondiles BR; Wei H; Chaboub LS; Horner PJ; Wu JQ; Perlmutter SI
Sci Data; 2021 Jul; 8(1):175. PubMed ID: 34267212
[TBL] [Abstract][Full Text] [Related]
16. Experience, cortical remapping, and recovery in brain disease.
Wittenberg GF
Neurobiol Dis; 2010 Feb; 37(2):252-8. PubMed ID: 19770044
[TBL] [Abstract][Full Text] [Related]
17. Overexpressing eukaryotic elongation factor 1 alpha (eEF1A) proteins to promote corticospinal axon repair after injury.
Romaus-Sanjurjo D; Saikia JM; Kim HJ; Tsai KM; Le GQ; Zheng B
Cell Death Discov; 2022 Sep; 8(1):390. PubMed ID: 36123349
[TBL] [Abstract][Full Text] [Related]
18. LOTUS, a potent blocker of Nogo receptor-1 causing inhibition of axonal growth.
Kurihara Y; Takei K
Neural Regen Res; 2015 Jan; 10(1):46-8. PubMed ID: 25788917
[No Abstract] [Full Text] [Related]
19. Nogo receptor antagonist LOTUS exerts suppression on axonal growth-inhibiting receptor PIR-B.
Kurihara Y; Takai T; Takei K
J Neurochem; 2020 Nov; 155(3):285-299. PubMed ID: 32201946
[TBL] [Abstract][Full Text] [Related]
20. Commentary: Development of a new concept is achieved only step-by-step.
Chen-Yoshikawa TF; Nakajima D
J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1656-1657. PubMed ID: 31677886
[No Abstract] [Full Text] [Related]
[Next] [New Search]
